Skip to Main Content

Paper Details

Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine.
NPJ Breast Cancer
14
2017
95 genes, 95-gene prognostic signature, Exemestane, Tamoxifen, breast cancer, breast or other malignancies, early breast cancer, hormone, mRNA, patients, receptor tyrosine, tyrosine, women
Author NameAffiliation
Jane BayaniOntario Institute for Cancer Research
Cindy Q YaoOntario Institute for Cancer Research
Mary Anne QuintayoOntario Institute for Cancer Research
Fu Jian YanOntario Institute for Cancer Research
Syed HaiderOntario Institute for Cancer Research
Alister D'CostaOntario Institute for Cancer Research
Cassandra L BrookesCancer Research UK Clinical Trials Unit, University of Birmingham
Cornelis J H van de VeldeLeiden University Medical Center
Annette HasenburgUniversity of Mainz
Dirk G KiebackHelios Medical Center
Christos MarkopoulosAthens University Medical School
Luc DirixSt. Augustinus Hospital
Caroline SeynaeveErasmus MC Cancer Institute
Daniel ReaCancer Research UK Clinical Trials Unit, University of Birmingham
Paul C BoutrosOntario Institute for Cancer Research
Paul C BoutrosUniversity of Toronto
John M S BartlettOntario Institute for Cancer Research
John M S BartlettCancer Research UK Clinical Trials Unit, University of Birmingham
John M S BartlettUniversity of Toronto
  • 1 - 19

Datasets

Release 1.2